NUSConsumer Defensive · Household & Personal ProductsTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 65 of 100 as at 22 Oct 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Nu Skin Enterprises, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (99): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Momentum (12): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on NUS, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 20 Dec 2024 | DA Davidson | Maintains | Neutral | $11 → $7.00 |
| 22 Oct 2024 | Citigroup | Maintains | Neutral | — |
| 12 Aug 2024 | DA Davidson | Maintains | Neutral | — |
| 9 Aug 2024 | Citigroup | Maintains | Neutral | — |
| 9 May 2024 | DA Davidson | Maintains | Neutral | — |
| 5 Jan 2024 | DA Davidson | Maintains | Neutral | — |
| 16 Oct 2023 | Stifel | Maintains | Hold | — |
| 29 Sept 2023 | Citigroup | Maintains | Neutral | — |
| 3 Aug 2023 | DA Davidson | Reiterates | Neutral | — |
| 2 Aug 2023 | Stifel | Maintains | Hold | — |
| 19 May 2023 | DA Davidson | Reiterates | Neutral | — |
| 1 Mar 2023 | Citigroup | Maintains | Neutral | — |
| 16 Feb 2023 | DA Davidson | Maintains | Neutral | — |
| 31 Jan 2023 | Jefferies | Downgrade | Hold | — |
| 23 Nov 2022 | DA Davidson | Maintains | Neutral | — |
| 5 Oct 2022 | Citigroup | Maintains | Neutral | — |
| 23 Aug 2022 | DA Davidson | Maintains | Neutral | — |
| 8 Aug 2022 | Citigroup | Maintains | Neutral | — |
| 5 May 2022 | DA Davidson | Maintains | Neutral | — |
| 17 Feb 2022 | DA Davidson | Maintains | Neutral | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
NUS appears in the Radar on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 23 Oct 2026, Nu Skin Enterprises, Inc. returned −54.6% against +14.3% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 66% of US stocks
Cheaper than 93% of US stocks
Cheaper than 85% of US stocks
Cheaper than 56% of US stocks
Higher than 12% of US stocks
Higher than 22% of US stocks
Higher than 81% of US stocks
Higher than 57% of US stocks
Higher than 17% of US stocks
Higher than 26% of US stocks
Higher than 68% of US stocks
Higher than 93% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Nu Skin Enterprises, Inc. has a market value of $231.7M and an enterprise value of $328.4M.
Revenue in the twelve months to 30 June 2026: $1.4B. The latest quarter shrank 17.1% year on year.
Net income over the same four quarters: −$216.4M, a −15.7% net margin.
Diluted earnings per share, trailing twelve months: $−4.47.
Free cash flow in the twelve months to 30 June 2026: $10.8M.
Nu Skin Enterprises, Inc. spent $20.0M on share buybacks and $11.7M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 4.8×; forward P/E: 4.1× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 5.04%, paying out 22% of earnings.
Nu Skin Enterprises, Inc. employs 2,800 people — $491K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Nu Skin Enterprises, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Nu Skin Enterprises said it will release third-quarter 2026 results after market close on Thursday, Nov. 5. Management will hold a conference call at 5 p.m. ET that day to discuss results and upcoming business initiatives.
Why it matters — The announcement gives NUS watchers the timing and format for the company’s next financial update and management discussion.
Nu Skin Enterprises has been ranked the world's No. 1 company for beauty and wellness device systems by Euromonitor International for the third consecutive year. The company's CEO described the recognition as validation of its long-term vision and commitment to innovation.
Why it matters — This external recognition of its device systems underscores Nu Skin's market leadership and brand standing in the beauty and wellness category.
Stonegate Capital Partners updated its coverage on NU Skin Enterprises Inc. after the company reported revenue of $320.1 million, adjusted net income of $10.0 million, and adjusted EPS of $0.20 for 2Q26.
Why it matters — The update provides NUS watchers with fresh analyst attention and reported financial figures for the second quarter of 2026.
Nu Skin Enterprises reported second-quarter results that met analyst estimates, though revenues fell 17.1% year-over-year and EPS declined 53.5%. The company also lowered its 2026 revenue and adjusted EPS outlooks.
Why it matters — Nu Skin watchers would care because the steep year-over-year revenue and earnings declines, along with the reduced 2026 guidance, signal sustained pressure on the company's performance and future expectations.
Nu Skin Enterprises, Inc. published its Q2 2026 earnings call transcript on Seeking Alpha, covering the company's second-quarter results and management commentary.
Why it matters — Investors following Nu Skin can review management's discussion of the company's latest quarterly performance directly from the call.
As at 22 Oct 2026, Nu Skin Enterprises, Inc. ranks 65 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (99 of 100).
No analyst covering Nu Skin Enterprises, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NUS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $13 to $13 over the next 12 months.
Nu Skin Enterprises, Inc. returned -54.6% over the 12 months to 23 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Nu Skin Enterprises Inc. Class A is a consumer health and personal care company that develops and distributes beauty and wellness products worldwide.
The most recent item we track (Business Wire, 22 Oct 2026): "Nu Skin Enterprises to Announce Third Quarter 2026 Financial Results". Nu Skin Enterprises said it will release third-quarter 2026 results after market close on Thursday, Nov. 5. Management will hold a conference call at 5 p.m. ET that day to discuss results and upcoming business initiatives.
Nu Skin Enterprises Inc. Class A is a consumer health and personal care company that develops and distributes beauty and wellness products worldwide. The company offers a broad portfolio that includes skin care systems and devices, cosmetics, nutritional supplements, weight-management products, and other personal care solutions under brands such as Nu Skin, Pharmanex, and ageLOC. Its business is centered on direct selling and person-to-person marketing, supported by digital tools and a network of independent distributors. Nu Skin serves customers across multiple international markets, with a focus on beauty, anti-aging, and wellness categories. The company plays a role in the global consumer products market by combining product development, brand marketing, and distributed sales channels to reach households and individual consumers.
CEO Mr. Ryan S. Napierski · 2,800 employees · United States · https://www.nuskin.com
